Duysinx B, Corhay JL, Larock MP, Withofs N, Bury T, Hustinx R, Louis R. Contribution of positron emission tomography in pleural disease.
Rev Mal Respir 2010;
27:e47-53. [PMID:
20965393 DOI:
10.1016/j.rmr.2009.12.003]
[Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
INTRODUCTION
Positron emission tomography (PET) now plays a clear role in oncology, especially in chest tumours. We discuss the value of metabolic imaging in characterising pleural pathology in the light of our own experience and review the literature.
BACKGROUND
PET is particularly useful in characterising malignant pleural pathologies and is a factor of prognosis in mesothelioma. Metabolic imaging also provides clinical information for staging lung cancer, in researching the primary tumour in metastatic pleurisy and in monitoring chronic or recurrent pleural pathologies.
CONCLUSIONS
PET should therefore be considered as a useful tool in the diagnosis of liquid or solid pleural pathologies.
Collapse